Phaeno Thera Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
8
Phaeno Thera General Information
Description
Developer of anti-infective therapeutics designed to prevent and treat infectious diseases. The company offers internally developed antiviral and antibacterial drug candidates targeting herpesvirus, cytomegalovirus, influenza, and drug-resistant bacterial infections, enabling patients and healthcare providers to address infectious diseases with new therapeutic options.
Contact Information
Website
www.phaenothera.comCorporate Office
- Room 201-18, Building 6, Zhangjiang Microelectronics Port
- Number 690 Bibo Road, Pudong New Area
- Shanghai, 900000
- China
Corporate Office
- Room 201-18, Building 6, Zhangjiang Microelectronics Port
- Number 690 Bibo Road, Pudong New Area
- Shanghai, 900000
- China
Phaeno Thera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 03-Sep-2026 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series 1) | 19-Jan-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 31-Aug-2021 | $15.4M | $24.1M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 14-Jun-2019 | $8.69M | $8.69M | Completed | Startup |
Phaeno Thera Comparisons
Industry
Financing
Details
Phaeno Thera Competitors (6)
One of Phaeno Thera’s 6 competitors is Merck & Co., a Corporation company based in Rahway, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Assembly Biosciences | Formerly VC-backed | South San Francisco, CA | ||||
| AiCuris | Formerly VC-backed | Wuppertal, Germany | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| Shionogi Pharma | Corporation | Settsu, Japan |
Phaeno Thera Signals
Phaeno Thera Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascentage Pharma | Corporation | Minority | ||
| Grains Valley Venture Capital | Venture Capital | Minority | ||
| BrightGene Bio-Medical Technology Company | Corporation | Minority | ||
| Laurel Venture Capital | Venture Capital | Minority | ||
| WinDigital Capital Management | Venture Capital | Minority |
Phaeno Thera FAQs
-
When was Phaeno Thera founded?
Phaeno Thera was founded in 2018.
-
Where is Phaeno Thera headquartered?
Phaeno Thera is headquartered in Shanghai, China.
-
What is the size of Phaeno Thera?
Phaeno Thera has 10 total employees.
-
What industry is Phaeno Thera in?
Phaeno Thera’s primary industry is Drug Discovery.
-
Is Phaeno Thera a private or public company?
Phaeno Thera is a Private company.
-
What is Phaeno Thera’s current revenue?
The current revenue for Phaeno Thera is .
-
How much funding has Phaeno Thera raised over time?
Phaeno Thera has raised $24.1M.
-
Who are Phaeno Thera’s investors?
Ascentage Pharma, Grains Valley Venture Capital, BrightGene Bio-Medical Technology Company, Laurel Venture Capital, and WinDigital Capital Management are 5 of 8 investors who have invested in Phaeno Thera.
-
Who are Phaeno Thera’s competitors?
Merck & Co., Assembly Biosciences, AiCuris, Roche, and Shionogi Pharma are some of the 6 competitors of Phaeno Thera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process